“…1,4,13 However, the seroprevalence of rubella immunity in the current study was higher than findings from other countries like southern India (65%), Niger (53%), and lower than findings from Nigeria (97.9%), Mexico (97.1%), Turkey (96.1%), Spain (94.1%), Western Province in KSA (91.6%), Cameroon (88.6%) and Kuwait (88.4%). 1,3,14,15 The differences in seroprevalence between different studies could be attributed to the variation in the epidemiology of the infection, the differences in the sample size and the methodology of the studies, the utilised laboratory tests, discrepancies in the used cut-off points used to confirm the immunity, and the involvement of rubella immunisation in their national vaccination programs. 1,16 There were no significant variations in antenatal characteristics of patients between susceptible and immune groups.…”